Neogenomics (NEO) Amortization of Deferred Charges (2016 - 2025)
Historic Amortization of Deferred Charges for Neogenomics (NEO) over the last 16 years, with Q3 2025 value amounting to $9000.0.
- Neogenomics' Amortization of Deferred Charges fell 8085.11% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $126000.0, marking a year-over-year decrease of 3262.03%. This contributed to the annual value of $189000.0 for FY2024, which is 216.22% up from last year.
- Neogenomics' Amortization of Deferred Charges amounted to $9000.0 in Q3 2025, which was down 8085.11% from $21000.0 recorded in Q2 2025.
- In the past 5 years, Neogenomics' Amortization of Deferred Charges registered a high of $48000.0 during Q4 2024, and its lowest value of $9000.0 during Q3 2025.
- For the 5-year period, Neogenomics' Amortization of Deferred Charges averaged around $42736.8, with its median value being $46000.0 (2022).
- In the last 5 years, Neogenomics' Amortization of Deferred Charges skyrocketed by 7307.69% in 2021 and then crashed by 8085.11% in 2025.
- Quarter analysis of 5 years shows Neogenomics' Amortization of Deferred Charges stood at $45000.0 in 2021, then increased by 2.22% to $46000.0 in 2022, then changed by 0.0% to $46000.0 in 2023, then increased by 4.35% to $48000.0 in 2024, then crashed by 81.25% to $9000.0 in 2025.
- Its Amortization of Deferred Charges stands at $9000.0 for Q3 2025, versus $21000.0 for Q2 2025 and $48000.0 for Q1 2025.